Sevoflurane ameliorates gas exchange and attenuates lung damage in experimental lipopolysaccharide-induced lung injury

Anesthesiology

Volumn 111, Issue 6, 2009, Pages 1238-1248

  Voigtsberger, Stefanie ^a   Lachmann, Robert A ^a   Leutert, Anik C ^a   Schläpfer, Martin ^a   Booy, Christa ^b   Reyes, Livia ^a   Urner, Martin ^a   Schild, Julia ^a   Schimmer, Ralph C ^a   Beck Schimmer, Beatrice ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Center for Integrative Human Physiology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPID; PROPOFOL; SEVOFLURANE; SODIUM CHLORIDE; SURFACTANT PROTEIN B; CCL2 PROTEIN, RAT; CHEMOKINE; CXCL1 CHEMOKINE; CXCL1 PROTEIN, RAT; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; LUNG SURFACTANT; RNA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; ATTENUATION; CELL COUNT; CONDITIONING; CONTROLLED STUDY; DISEASE DURATION; EFFECTOR CELL; GAS EXCHANGE; GENERAL ANESTHESIA; HISTOPATHOLOGY; IN VIVO CULTURE; LUNG FUNCTION; LUNG LAVAGE; LUNG PARENCHYMA; MALE; NONHUMAN; OXYGEN TENSION; PERMEABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRACHEOTOMY; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HYPERCAPNIA; ISOLATION AND PURIFICATION; LUNG DISEASE; LUNG GAS EXCHANGE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PULMONARY ARTERY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT;

ANESTHETICS, INHALATION; ANIMALS; BLOOD PRESSURE; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CXCL1; CHEMOKINES; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERCAPNIA; LIPOPOLYSACCHARIDES; LUNG DISEASES; MALE; METHYL ETHERS; PERMEABILITY; PHOSPHOLIPIDS; PROPOFOL; PULMONARY ARTERY; PULMONARY GAS EXCHANGE; PULMONARY SURFACTANTS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 73449087678     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181bdf857     Document Type: Article

References (57)

1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD: Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:1685-1693
2. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet 1967; 2:319-323
3. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, Scales DC, Stather DR, Li A, Jones A, Gattas DJ, Hallett D, Tomlinson G, Stewart TE, Ferguson ND: Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 2009; 179:220-227
4. Girard TD, Bernard GR: Mechanical ventilation in ARDS: A state-of-the-art review. Chest 2007; 131:921-929
5. Pittet JF, Mackersie RC, Martin TR, Matthay MA: Biological markers of acute lung injury: Prognostic and pathogenetic significance. Am J Respir Crit Care Med 1997; 155:1187-1205
6. Belda JF, Soro M, Badenes R, Meiser A, Garcia ML, Aguilar G, Marti FJ: The predictive performance of a pharmacokinetic model for manually adjusted infusion of liquid sevoflurane for use with the Anesthetic-Conserving Device (AnaConDa): A clinical study. Anesth Analg 2008; 106:1207-1214
7. Suter D, Spahn DR, Blumenthal S, Reyes L, Booy C, Z'Graggen BR, Beck-Schimmer B: The immunomodulatory effect of sevoflurane in endotoxin-injured alveolar epithelial cells. Anesth Analg 2007; 104:638-645
8. Reutershan J, Chang D, Hayes JK, Ley K: Protective effects of isoflurane pretreatment in endotoxin-induced lung injury. ANESTHESIOLOGY 2006; 104:511-517
9. Beck-Schimmer B, Urech S, De Conno E, Wittlinger M, Puhan M, Jochum W, Spahn DR, Clavien PA: A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008; 248: 909-918
10. Yue T, Roth Z'graggen B, Blumenthal S, Neff SB, Reyes L, Booy C, Steurer M, Spahn DR, Neff TA, Schmid ER, Beck-Schimmer B: Postconditioning with a volatile anaesthetic in alveolar epithelial cells in vitro. Eur Respir J 2008; 31: 118-125
11. Riess ML, Stowe DF, Warltier DC: Cardiac pharmacological preconditioning with volatile anesthetics: From bench to bedside? Am J Physiol Heart Circ Physiol 2004; 286:H1603-7
12. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC: Mechanisms of cardioprotection by volatile anesthetics. ANESTHESIOLOGY 2004; 100:707-721
13. Lee HT, Ota-Setlik A, Fu Y, Nasr SH, Emala CW: Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. ANESTHESIOLOGY 2004; 101:1313-1324
14. Liu R, Ishibe Y, Ueda M: Isoflurane-sevoflurane administration before ischemia attenuates ischemia-reperfusion-induced injury in isolated rat lungs. ANESTHESIOLOGY 2000; 92:833-840
15. Kalb R, Schober P, Schwarte LA, Weimann J, Loer SA: Preconditioning, but not postconditioning, with sevoflurane reduces pulmonary neutrophil accumulation after lower body ischaemia/reperfusion injury in rats. Eur J Anaesthesiol 2008; 25:454-459
16. Beck-Schimmer B, Madjdpour C, Kneller S, Ziegler U, Pasch T, Wuthrich RP, Ward PA, Schimmer RC: Role of alveolar epithelial ICAM-1 in lipopolysac-charide-induced lung inflammation. Eur Respir J 2002; 19:1142-1150
17. Baker MT, Naguib M: Propofol: The challenges of formulation. ANESTHESI-OLOGY 2005; 103:860-876
18. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25:402-408
19. Chen HI, Hsieh NK, Kao SJ, Su CF: Protective effects of propofol on acute lung injury induced by oleic acid in conscious rats. Crit Care Med 2008; 36: 1214-1221
20. Chen HI, Yeh DY, Liou HL, Kao SJ: Insulin attenuates endotoxin-induced acute lung injury in conscious rats. Crit Care Med 2006; 34:758-764
21. Stewart JC: Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 1980; 104:10-14
22. Douglas WH, Kaighn ME: Clonal isolation of differentiated rat lung cells. In Vitro 1974; 10:230-237
23. Ishibe Y, Gui X, Uno H, Shiokawa Y, Umeda T, Suekane K: Effect of sevoflurane on hypoxic pulmonary vasoconstriction in the perfused rabbit lung. ANESTHESIOLOGY 1993; 79:1348-1353
24. Domino KB, Borowec L, Alexander CM, Williams JJ, Chen L, Marshall C, Marshall BE: Influence of isoflurane on hypoxic pulmonary vasoconstriction in dogs. ANESTHESIOLOGY 1986; 64:423-429
25. Schwarzkopf K, Schreiber T, Preussler NP, Gaser E, Huter L, Bauer R, Schubert H, Karzai W: Lung perfusion, shunt fraction, and oxygenation during one-lung ventilation in pigs: The effects of desflurane, isoflurane, and propofol. J Cardiothorac Vasc Anesth 2003; 17:73-75
26. Beck DH, Doepfmer UR, Sinemus C, Bloch A, Schenk MR, Kox WJ: Effects of sevoflurane and propofol on pulmonary shunt fraction during one-lung ventilation for thoracic surgery. Br J Anaesth 2001; 86:38-43
27. Pruszkowski O, Dalibon N, Moutafis M, Jugan E, Law-Koune JD, Laloe PA, Fischler M: Effects of propofol versus sevoflurane on arterial oxygenation during one-lung ventilation. Br J Anaesth 2007; 98:539-544
28. Johnston B, Burns AR, Suematsu M, Issekutz TB, Woodman RC, Kubes P: Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1. J Clin Invest 1999; 103:1269-1276
29. Vozzelli MA, Mason SN, Whorton MH, Auten RL Jr: Antimacrophage chemo-kine treatment prevents neutrophil and macrophage influx in hyperoxia-exposed newborn rat lung. Am J Physiol Lung Cell Mol Physiol 2004; 286:L488-93
30. Watanabe T, Higuchi K, Hamaguchi M, Shiba M, Tominaga K, Fujiwara Y, Matsumoto T, Arakawa T: Monocyte chemotactic protein-1 regulates leukocyte recruitment during gastric ulcer recurrence induced by tumor necrosis factor-alpha. Am J Physiol Gastrointest Liver Physiol 2004; 287:G919-28
31. Yamasawa H, Ishii Y, Kitamura S: Cytokine-induced neutrophil chemoat-tractant in a rat model of lipopolysaccharide-induced acute lung injury. Inflammation 1999; 23:263-274
32. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824 (Pubitemid 24082248)
33. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM, Garcia JG: Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 2004; 169:1245-1251 (Pubitemid 38680403)
34. Ingenito EP, Mora R, Cullivan M, Marzan Y, Haley K, Mark L, Sonna LA: Decreased surfactant protein-B expression and surfactant dysfunction in a murine model of acute lung injury. Am J Respir Cell Mol Biol 2001; 25:35-44
35. Pryhuber GS, Bachurski C, Hirsch R, Bacon A, Whitsett JA: Tumor necrosis factor-alpha decreases surfactant protein B mRNA in murine lung. Am J Physiol 1996; 270:L714-21
36. Quintero OA, Korfhagen TR, Wright JR: Surfactant protein A regulates surfactant phospholipid clearance after LPS-induced injury in vivo. Am J Physiol Lung Cell Mol Physiol 2002; 283:L76-85
37. Takala RS, Soukka HR, Kirvela OA, Kujari HP, Pelliniemi LJ, Kaapa PO, Aantaa RE: Alveolar integrity and ultrastructure in pigs remain undamaged after exposure to sevoflurane. Acta Anaesthesiol Scand 2002; 46:1137-1143
38. Takala RS, Soukka H, Salo MS, Kirvela O, Kaapa P, Aantaa R: Gene expression of pulmonary cytokines after sevoflurane or thiopentone anaesthesia in pigs. Acta Anaesthesiol Scand 2006; 50:163-167
39. Takala RS, Soukka HR, Salo MS, Kirvela OA, Kaapa PO, Rajamaki AA, Riutta A, Aantaa RE: Pulmonary inflammatory mediators after sevoflurane and thiopen-tone anaesthesia in pigs. Acta Anaesthesiol Scand 2004; 48:40-45
40. Sung EG, Jee D, Song IH, Kim HS, Bae JH, Park SH: Propofol attenuates Kupffer cell activation during hypoxia-reoxygenation. Can J Anaesth 2005; 52: 921-926
41. Fourcade O, Simon MF, Litt L, Samii K, Chap H: Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators. Anesth Analg 2004; 99:393-398
42. Chikutei K, Oyama TM, Ishida S, Okano Y, Kobayashi M, Matsui H, Horimoto K, Nishimura Y, Ueno SY, Oyama Y: Propofol, an anesthetic possessing neuroprotective action against oxidative stress, promotes the process of cell death induced by H2O2 in rat thymocytes. Eur J Pharmacol 2006; 540:18-23
43. Shao H, Li J, Zhou Y, Ge Z, Fan J, Shao Z, Zeng Y: Dose-dependent protective effect of propofol against mitochondrial dysfunction in ischaemic/ reperfused rat heart: Role of cardiolipin. Br J Pharmacol 2008; 153:1641-1649
44. Wang B, Luo T, Chen D, Ansley DM: Propofol reduces apoptosis and up-regulates endothelial nitric oxide synthase protein expression in hydrogen peroxide-stimulated human umbilical vein endothelial cells. Anesth Analg 2007; 105:1027-1033
45. Lang JD Jr, Chumley P, Eiserich JP, Estevez A, Bamberg T, Adhami A, Crow J, Freeman BA: Hypercapnia induces injury to alveolar epithelial cells via a nitric oxide-dependent pathway. Am J Physiol Lung Cell Mol Physiol 2000; 279:L994-1002
46. Hofstetter C, Boost KA, Flondor M, Basagan-Mogol E, Betz C, Homann M, Muhl H, Pfeilschifter J, Zwissler B: Anti-inflammatory effects of sevoflurane and mild hypothermia in endotoxemic rats. Acta Anaesthesiol Scand 2007; 51:893-899
47. Kato R, Foex P: Myocardial protection by anesthetic agents against isch-emia-reperfusion injury: An update for anesthesiologists. Can J Anaesth 2002; 49:777-791
48. Taniguchi T, Kanakura H, Yamamoto K: Effects of posttreatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats. Crit Care Med 2002; 30:904-907
49. Taniguchi T, Yamamoto K, Ohmoto N, Ohta K, Kobayashi T: Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med 2000; 28:1101-1106
50. Gao J, Zeng BX, Zhou LJ, Yuan SY: Protective effects of early treatment with propofol on endotoxin-induced acute lung injury in rats. Br J Anaesth 2004; 92:277-279
51. Hsu BG, Yang FL, Lee RP, Peng TC, Chen HI: Effects of post-treatment with low-dose propofol on inflammatory responses to lipopolysaccharide-induced shock in conscious rats. Clin Exp Pharmacol Physiol 2005; 32:24-29
52. Herr DL, Kelly K, Hall JB, Ulatowski J, Fulda GJ, Cason B, Hickey R, Nejman AM, Zaloga GP, Teres D: Safety and efficacy of propofol with EDTA when used for sedation of surgical intensive care unit patients. Intensive Care Med 2000; 26 (Suppl 4):S452-62
53. De Conno E, Steurer MP, Wittlinger M, Zalunardo MP, Weder W, Schneiter D, Schimmer RC, Klaghofer R, Neff TA, Schmid ER, Spahn DR, Z'Graggen BR, Urner M, Beck-Schimmer B: Anesthetic-induced improvement of the inflammatory response to one-lung ventilation. ANESTHESIOLOGY 2009; 110:1316-1326
54. Rohm KD, Wolf MW, Schollhorn T, Schellhaass A, Boldt J, Piper SN: Short-term sevoflurane sedation using the Anaesthetic Conserving Device after cardiothoracic surgery. Intensive Care Med 2008; 34:1683-1689
55. Brigham KL, Meyrick B: Endotoxin and lung injury. Am Rev Respir Dis 1986; 133:913-927
56. Wang HM, Bodenstein M, Markstaller K: Overview of the pathology of three widely used animal models of acute lung injury. Eur Surg Res 2008; 40:305-316
57. Tateda K, Deng JC, Moore TA, Newstead MW, Paine R III, Kobayashi N, Yamaguchi K, Standiford TJ: Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: The role of apoptosis. J Immunol 2003; 170:4209-4216